The Chronic Lymphocytic Leukemia Channel is supported with funding from AstraZeneca (Diamond), Johnson & Johnson (Gold) and Lilly (Silver).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ERIC CLL 2026 | The CLL microenvironment: insights into interactions driving proliferation and therapy resistance
Tanja Hartmann, MD, University Medical Center Freiburg, Freiburg, Germany, discusses the crucial interactions between chronic lymphocytic leukemia (CLL) cells and their microenvironment. Prof. Hartmann emphasizes that CLL cells rely on these interactions to proliferate and develop resistance to common therapies, making the microenvironment a key factor in disease progression. This interview took place at the 2026 ERIC International Meeting in Barcelona, Spain.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
